Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-18T22:53:08.686Z Has data issue: false hasContentIssue false
  • English
  • Français

Acupuncture-like transcutaneous nerve stimulation therapy success after 5 years post-radiation-induced xerostomia: a case report

Published online by Cambridge University Press:  11 January 2016

Ami Patel-Yadav  and
Anurag Singh
Ami Patel-Yadav
Affiliation:
Department of Radiation Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA
Anurag Singh*
Affiliation:
Department of Radiation Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA
*
Correspondence to: Dr Anurag Singh, Department of Radiation Oncology, Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, NY 14263, USA. Tel: 1 716 845 1180. Fax: 1 716 845 7616. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Success with acupuncture-like transcutaneous nerve stimulation (ALTENS) in the treatment of radiation-induced xerostomia has not been reported after an extended time.

Methods

We report a case of successful ALTENS therapy 5 years after radiation treatment.

Results

The patient discontinued treatments in a second course due to complete resolution of symptoms.

Conclusion

This case report demonstrates a potential for offering ALTENS to those long suffering from radiation-induced xerostomia.

Keywords

acupuncture-like transcutaneous nerve stimulationALTENSradiation-induced xerostomia
Type
Case Study
Information
Journal of Radiotherapy in Practice , Volume 15 , Issue 2 , June 2016 , pp. 215 - 217
Copyright
© Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Bruce, S D. Radiation-induced xerostomia: how dry is your patient? Clin J Oncol Nurs 2004; 8: 61–67.CrossRefGoogle ScholarPubMed
2.Warde, P, O’Sullivan, B, Aslanidis, Jet al. A phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002; 54: 9–13.CrossRefGoogle ScholarPubMed
3.Wong, R K, Jones, G W, Sagar, S M, Babjak, A F, Whelan, T. A phase I-II study in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiation-induced xerostomia in head-and-neck cancer patients treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2003; 57: 472–480.CrossRefGoogle ScholarPubMed
4.Jensen, S B, Pedersen, A M, Reibel, J, Nauntofte, B. Xerostomia and hypofunction of the salivary glands in cancer therapy. Support Care Cancer 2003; 11: 207–225.CrossRefGoogle ScholarPubMed
5.Nauntofte, B, Tenovuo, J, Lagerlöf, F. Secretion and composition of saliva. In: Ole Fejerskov (ed.). Dental Caries the Disease and its Clinical Management. Oxford: Blackwell Munksgaard, 2003: 7–29.Google Scholar
6.Wong, R K, Deshmukh, S, Wyatt, Get al. Acupuncture-like transcutaneous electrical nerve stimulation versus pilocarpine in treating radiation-induced xerostomia: results of RTOG 0537 phase 3 study. Int J Radiat Oncol Biol Phys 2015; 92 (2): 220–227.CrossRefGoogle ScholarPubMed
7.Eisbruch, A, Kim, H M, Terrell, J E, Marsh, L H, Dawson, L A, Ship, J A. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 50: 695–704.Google ScholarPubMed
8.Wong, R K, James, J L, Sagar, Set al. Phase 2 results from Radiation Therapy Oncology Group Study 0537: a phase 2/3 study comparing acupuncture-like transcutaneous electrical nerve stimulation versus pilocarpine in treating early radiation-induced xerostomia. Cancer 2012; 118: 4244–4252.CrossRefGoogle Scholar
9.Mix, M. Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck. World J Clin Oncol 2015; 6: 166–173.CrossRefGoogle ScholarPubMed
10.Henson, B S. Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral Oncol 2000; 37: 84–93.CrossRefGoogle Scholar